Browsing: Press Release

Singapore, 26 May 2025 – Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) and Antimicrobial Resistance (AMR) interdisciplinary research groups (IRGs) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, and KK Women’s and Children’s Hospital (KKH), have developed a first-of-its-kind device to profile the immune function of newborns.   

Singapore, 14 May 2025 – The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils who are on a stable combination of an inhaled corticosteroid (ICS), a long-acting beta2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA), or on a combination of a LABA and a LAMA if ICS is not appropriate.

Log In or Register as a healthcare professional to read the full article.